Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- B. Riley Securities analyst Eric Wold downgraded the rating for Cinemark Holdings, Inc. CNK from Buy to Neutral and maintained the price target of $31. Cinemark shares gained 1.3% to close at $28.17 on Monday. See how other analysts view this stock.
- Citigroup analyst Thomas Palmer downgraded The Hershey Company HSY from Neutral to Sell and slashed the price target from $195 to $182. Hershey shares rose 0.04% to close at $196.41 on Monday. See how other analysts view this stock.
- Alembic Global analyst Peter Skibitski downgraded the rating for Northrop Grumman Corporation NOC from Overweight to Neutral and announced a price target of $560. Northrop Grumman shares gained 0.5% to close at $512.00 on Monday. See how other analysts view this stock.
- Citigroup analyst Alicia Yap downgraded PDD Holdings Inc. PDD from Buy to Neutral and cut the price target from $194 to $120. PDD shares dipped 28.5% to settle at $100.00 on Monday. See how other analysts view this stock.
- Maxim Group analyst Jason McCarthy downgraded the rating for Cyclo Therapeutics, Inc. CYTH from Buy to Hold. Cyclo Therapeutics shares rose 6.1% to close at $0.8277 on Monday. See how other analysts view this stock.
Considering buying HSY stock? Here’s what analysts think:
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/27085814/image-268-1024x517.png)
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in